Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021

Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021

Abstract Atrial fibrillation (AF) and atrial flutter (AFL) are cardiac arrhythmias associated with high morbidity and mortality. This cross-sectional observational study assesses the epidemiological burden of AF/AFL concerning metabolic risk factors using the Global Burden of Disease (GBD) 2021 data...

Full description

Saved in:

Bibliographic Details
Main Authors:	Junqing Liang, Jun Shen, Yankai Guo, Manzeremu Rejiepu, Xiuwen Ling, Xiaoyan Wang, Yi Jian, Xing Zhang, Shijie Shao, Baopeng Tang, Ling Zhang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Series:	Scientific Reports
Subjects:	Global burden of disease Atrial fibrillation/atrial flutter Metabolic risk factors
Online Access:	https://doi.org/10.1038/s41598-025-88744-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021
by: Xia Li, et al.
Published: (2025-05-01)

Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021
by: Xiaodong Peng, et al.
Published: (2025-03-01)

Secular trend in disease burden of atrial fibrillation/flutter in China from 1992 to 2021 and its projection in 25 years
by: Chuanmeng Zhang, et al.
Published: (2025-06-01)

Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study
by: Antti Lappalainen, et al.
Published: (2024-12-01)

COMPARISON RESULTS OF THE INTRACARDIAC ELECTROPHYSIOLOGICAL STUDY IN PATIENTS WITH TYPICAL ATRIAL FLUTTER AND FIBRILLATION
by: P. S. Novikov, et al.
Published: (2017-08-01)

Temporal Trend Analysis of Atrial Fibrillation/Flutter Disease Burden in High-Income Countries Between 1990 and 2021
by: Yuqiao Pang, et al.
Published: (2025-07-01)

Relief of persistent atypical atrial flutter: experience with the use of niferidil
by: E. A. Zakharyan, et al.
Published: (2023-03-01)

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

Global trends and regional disparities in atrial fibrillation and flutter burden attributable to high alcohol consumption: findings from the global burden of disease study 2021
by: Yunkai Hua, et al.
Published: (2025-04-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

EHRA classes, additional cardiovascular risk and quality of life in patients during the first six months of atrial flutter and atrial fibrillation radiofrequency
by: M. S. Brynza, et al.
Published: (2018-06-01)

Association of atrial fibrillation and atrial flutter with sick sinus syndrome: a review of the issue based on examples of clinical observations
by: O. Yu. Schmidt, et al.
Published: (2022-05-01)

Trends in atrial fibrillation and flutter mortality associated with disorders of thyroid gland in the United States from 1999 to 2020
by: Shahzaib Ahmed, et al.
Published: (2025-06-01)

Analysis and comparison of the trends in burden of atrial fibrillation/atrial flutter in China and worldwide from 1990 to 2021 and predictions to 2036 of China
by: Zhilin Wang, et al.
Published: (2025-05-01)

Comparative characteristics of different methods of radiofrequency catheter ablation in atrial flutter
by: A. V. Yakushev, et al.
Published: (2022-11-01)

The burden of atrial fibrillation/atrial flutter in Europe from 1990 to 2021, with a forecast of incidence through 2044
by: Min Xie, et al.
Published: (2025-06-01)

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation
by: M. A. Zelberg, et al.
Published: (2024-05-01)

Stroke prophylaxis after US emergency department diagnosis and discharge of patients with atrial fibrillation and flutter from 21 hospitals
by: Bory Kea, et al.
Published: (2025-05-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
by: Jean Michell Correia Monteiro, et al.

Trends in United States mortality among patients with atrial fibrillation/flutter related heart failure (1999–2024): disparities by gender, race/ethnicity and region
by: Suraksha Rani, et al.
Published: (2025-07-01)

Atrial fibrillation or flutter in patients undergoing stem cell transplantation, in-hospital and post-discharge outcomes in a large nationwide sample across the United States
by: Raja Zaghlol, et al.
Published: (2025-07-01)

Atrial fibrillation and flutter – the unsolved problem of medicine
by: A. G. Pronin, et al.
Published: (2024-09-01)

ATRIAL FLUTTER: CONTEMPORARY POSSIBILITIES OF DIAGNOSIS AND TREATMENT
by: Yu. A. Bunin
Published: (2016-01-01)

Clinical and Electrophysiological Predictors of Isthmus Dependency in Atrial Flutter
by: Lyuboslav Katov, et al.
Published: (2025-04-01)

Neonatal atrial flutter: Three cases and review of the literature
by: Seda Yılmaz-Semerci, et al.
Published: (2018-06-01)

ATRIAL FIBRILLATION OR FLUTTER IN THE EARLY POSTOPERATIVE PERIOD AFTER ASCENDING AORTA AND/OR AORTIC VALVE REPLACEMENT: RISK FACTORS, TREATMENT, PREVENTIVE MAINTENANCE
by: V. V. Ionova, et al.
Published: (2010-06-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Catheter ablation of typical right atrial flutter in a 20‐day‐old neonate with tachycardiomyopathy
by: Tiago Luiz Luz Leiria, et al.
Published: (2024-02-01)

The burden and trend prediction of atrial fibrillation and flutter associated with lead exposure: insights from the global burden of disease study 2021
by: Lili Deng, et al.
Published: (2025-08-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2021-11-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2021-05-01)

Comparison of traditional radiofrequency ablation and high-power short-duration ablation in the treatment of atrial tachyarrhythmias
by: A. V. Yakushev, et al.
Published: (2022-09-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Clinical assessment of transoesophageal electrostimulation in first-diagnosed Type I atrial flutter
by: A. I. Olesin, et al.
Published: (2008-06-01)

The preventive effect of sodium-glucose co-transporter-2 inhibitors on atrial fibrillation and atrial flutter in patients with chronic kidney disease: a meta-analysis
by: Qian Yang, et al.
Published: (2025-05-01)

Care for Atrial Fibrillation and Outcomes in Rural Versus Urban Communities in the United States: A Systematic and Narrative Review
by: Anthony L. Lin, et al.
Published: (2025-03-01)

From fluttering hearts to restless stomach: navigating atrial fibrillation, ablation and gastroparesis
by: Rabia Riasat, et al.
Published: (2025-06-01)

Efficacy of Adenosine in the Differential Diagnosis of Narrow QRS Complex Tachyarrhythmia: A Case Diagnosed with Atrial Flutter After Adenosine
by: Aziz Zeytin, et al.
Published: (2023-08-01)

Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy
by: Yu. A. Bunin, et al.
Published: (2019-03-01)

Global burden of atrial fibrillation and atrial flutter due to high alcohol use from 1990 to 2021: estimates from the global burden of disease study 2021
by: Xiaoming Wang, et al.
Published: (2025-07-01)